BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 11606384)

  • 1. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
    Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.
    van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M
    Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
    Butterworth M; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
    Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
    Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
    Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of DNA strand breaks and oxidized DNA bases at the single-cell level resulting from exposure to estradiol and hydroxylated metabolites.
    Rajapakse N; Butterworth M; Kortenkamp A
    Environ Mol Mutagen; 2005 May; 45(4):397-404. PubMed ID: 15662657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of metabolism on the genotoxicity of catechol estrogens in three cultured cell lines.
    Gerstner S; Glasemann D; Pfeiffer E; Metzler M
    Mol Nutr Food Res; 2008 Jul; 52(7):823-9. PubMed ID: 18618478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
    Butterworth M; Lau SS; Monks TJ
    Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol metabolites of zeranol and 17β-estradiol: a comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferase.
    Fleck SC; Hildebrand AA; Pfeiffer E; Metzler M
    Toxicol Lett; 2012 Apr; 210(1):9-14. PubMed ID: 22285433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
    Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
    Lehmann L; Jiang L; Wagner J
    Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase.
    Nagai M; Conney AH; Zhu BT
    Drug Metab Dispos; 2004 May; 32(5):497-504. PubMed ID: 15100171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity.
    Garner CE; Matthews HB; Burka LT
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):124-31. PubMed ID: 10637136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.
    Lu F; Zahid M; Saeed M; Cavalieri EL; Rogan EG
    J Steroid Biochem Mol Biol; 2007; 105(1-5):150-8. PubMed ID: 17582757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA.
    Lin PH; Nakamura J; Yamaguchi S; Asakura S; Swenberg JA
    Carcinogenesis; 2003 Jun; 24(6):1133-41. PubMed ID: 12807746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol
    Kim JH; Lee J; Jeong H; Bang MS; Jeong JH; Chang M
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the DNA damage threshold in breast cancer cells.
    Mobley JA; Brueggemeier RW
    Toxicol Appl Pharmacol; 2002 May; 180(3):219-26. PubMed ID: 12009861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.